Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2543628 | Journal of the American Pharmacists Association | 2009 | 6 Pages |
Abstract
These results support community pharmacy assertions of lower reimbursements from Part D payers compared with Medicaid payers. Based on these results, pharmacies can respond to this evolving environment by carefully reviewing their Part D plans' impact on CPGM and taking available steps to increase the proportion of generic drugs dispensed to Medicare beneficiaries.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Angela L. (Doctoral Candidate), Marvin D. (Professor), Kenneth A. (Associate Professor), Kristin M. (Research Associate),